Cardiovascular disease continues to be Mr. Mills’ primary area of focus as publishing Sell-side Medical Devices analyst over a career that spans nearly two decades. Mr. Mills also currently serves as the Head of US Healthcare Research for Canaccord Genuity, which he joined in 2007 from First Albany Capital, where he also served as Managing Director and Senior Medical Devices analyst. Prior to FAC, Mr. Mills served as a Vice President and Senior Med-Tech analyst at Thomas Weisel Partners (now part of Stifel). Mr. Mills has earned awards for his stock picking, including the #2 ranked Medical Devices analyst in the The Wall Street Journal’s 2011 ‘Best on the Street’ Survey and #1 in the Medical Products segment of Forbes 2010 Best Brokerage Analysts. Mr. Mills holds a BA in Economics from Yale University and Master of Sports Administration from Ohio University.